GE

Investors Brace for GE HealthCare to Hit the Market

Today Wall Street Journal is reporting: "GE HealthCare shares start trading this week, but investors are cautious about prospects for the spinoff of the power business." For full coverage click here. Shares of the large-cap Industrials company have not moved much on the news as of the afternoon trading session, and are currently trading at $83.79.

General Electric Company operates as a high-tech industrial company in Europe, China, Asia, the Americas, the Middle East, and Africa. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 21.46 and an average price to book (P/B) ratio of 3.7. In contrast, General Electric Company has a trailing 12 month P/E ratio of -18.5 and a P/B ratio of 2.9.

General Electric Company has moved -12.9% over the last year compared to -20.0% for the S&P 500 -- a difference of 7.0%. General Electric Company has a 52 week high of $103.73 and a 52 week low of $59.93. At today's price of $83.79 per share, General Electric Company is -7.01% away from its target price of $90.11, and on average, analysts give the stock a rating of buy. 1.4% of the company's shares are linked to short positions, and 71.8% of the shares are owned by institutional investors.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS